Results 141 to 150 of about 15,277 (204)

Correction: Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma. [PDF]

J Cancer Res Clin Oncol
Huang G, Chen L.
europepmc   +1 more source

Recombinant human‑endostatin combined with sintilimab and chemotherapy in first‑line treatment of locally advanced or metastatic esophageal squamous cell carcinoma. [PDF]

Oncol Lett
Cui S, Fan L, Sun X, Cai Y, Wang T, Li P, Wang R, Liu L.   +7 more
europepmc   +1 more source

Recombinant Human Endostatin [PDF]

, 2020
openaire   +1 more source

Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered. [PDF]

Transl Oncol
Chen P, Li K, Chen J, Hei H, Geng J, Huang N, Lei M, Jia H, Ren J, Jin C.   +9 more
europepmc   +1 more source

Proteoglycans in Prostate Cancer Progression and Therapy Resistance. [PDF]

Medicina (Kaunas)
Samaržija I.
europepmc   +1 more source

Non-invasive detection of bone marrow fibrosis in myeloproliferative neoplasms using cell-free RNA. [PDF]

iScience
Saad M, Fuchs SNR, Schalla C, Götz K, Pritchard JE, Flosdorf N, Benabid A, Gleitz HFE, Leimkühler N, Dugourd A, Schneider RK.   +10 more
europepmc   +1 more source

Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance. [PDF]

Cancer Biol Med
Serratì S, Raho L, De Giosa G, Porcelli L, Di Fonte R, Fasano R, Lacal PM, Graziani G, Iacobazzi RM, Azzariti A.   +9 more
europepmc   +1 more source

An Advanced IVB Lung Adenocarcinoma Patient With KRAS Mutations, Benefited From Camrelizumab Combined With Anti-Angiogenic Agents for Therapy: A Case Report. [PDF]

Cancer Rep (Hoboken)
Wang L, Wu J, Shao P, Bao W, Mao L, Pan Z, Bao A, Zhang M, Wu Z, Fan G.   +9 more
europepmc   +1 more source

Endostatin as a biomarker of systemic sclerosis: insights from a systematic review and meta-analysis. [PDF]

Front Immunol
Mangoni AA, Zinellu A.
europepmc   +1 more source

Combining recombinant human endostatin with third-generation EGFR-TKIs in advanced EGFR-sensitive mutant non-small cell lung cancer. [PDF]

J Thorac Dis
Chen J, Huang H, Zhong P, Lu Z, Ding X, Peng S, Zhu X, Wang F, Kong P, Tan AC, Song T, Xiao F, Chen L.   +12 more
europepmc   +1 more source